TD Asset Management Inc Sells 12,161 Shares of Humana Inc. $HUM

Key Points

• TD Asset Management Inc reduced its stake in Humana Inc. by 21.0%, selling 12,161 shares during the second quarter, resulting in holdings worth approximately $11.2 million.
• Analysts have varied perspectives on Humana's stock, with price targets ranging from $245.00 to $313.00, and eight analysts recommending a Buy rating.
• Humana recently declared a quarterly dividend of $0.885 per share, representing an annualized yield of 1.3% and a payout ratio of 27.17%.

TD Asset Management Inc lessened its stake in Humana Inc. (NYSE:HUM - Free Report) by 21.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 45,798 shares of the insurance provider's stock after selling 12,161 shares during the quarter. TD Asset Management Inc's holdings in Humana were worth $11,197,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Janney Montgomery Scott LLC bought a new stake in shares of Humana in the 1st quarter worth approximately $1,309,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Humana by 16.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider's stock worth $300,728,000 after purchasing an additional 158,528 shares during the period. Focus Partners Wealth raised its holdings in shares of Humana by 104.2% in the 1st quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider's stock worth $1,701,000 after purchasing an additional 3,281 shares during the period. Envestnet Asset Management Inc. raised its holdings in shares of Humana by 2.4% in the 1st quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider's stock worth $33,256,000 after purchasing an additional 2,950 shares during the period. Finally, Circle Wealth Management LLC bought a new stake in shares of Humana in the 1st quarter worth approximately $425,000. Institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research reports. Bank of America lifted their price target on shares of Humana from $280.00 to $300.00 and gave the stock a "neutral" rating in a report on Friday, October 10th. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Guggenheim reissued a "buy" rating on shares of Humana in a report on Friday, October 3rd. Wolfe Research boosted their target price on shares of Humana from $283.00 to $313.00 and gave the company an "outperform" rating in a report on Monday, October 6th. Finally, Barclays lowered their target price on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating on the stock in a report on Friday, October 3rd. Eight equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $297.58.

Humana Trading Up 2.9%

Humana stock opened at $275.00 on Friday. The stock has a market cap of $33.07 billion, a P/E ratio of 21.11, a PEG ratio of 1.61 and a beta of 0.42. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The firm's fifty day moving average price is $280.54 and its 200-day moving average price is $258.18. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana's dividend payout ratio is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.